Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|June 29, 2018
Ibrutinib for Treating Waldenström's Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPaul Tappenden, Christopher Carroll, John Stevens, et al.
Health Technology Assessment (Winchester, England)|July 1, 2026
Effectiveness of psychosocial interventions for adults with substance use disorder that have a co-occurring mental health disorder: an umbrella review and illustrative cost-effectiveness analysisEmma Simpson, Sunhong Kwon, Munira Essat, et al.
Pharmacoeconomics|October 19, 2015
Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMunira Essat, Paul Tappenden, Shijie Ren, et al.
Health Technology Assessment (Winchester, England)|March 2, 2019
Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic modelPaul Tappenden, Christopher Carroll, Jean Hamilton, et al.
Bone|October 19, 2019
Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysisE L Simpson, Marrissa Martyn-St James, Jean Hamilton, et al.
Pediatric Pulmonology|February 2, 2016
A systematic review of fractional exhaled nitric oxide in the routine management of childhood asthmaTim Gomersal, Sue Harnan, Munira Essat, et al.
Pharmacoeconomics|January 18, 2023
Living Health Technology Assessment: Issues, Challenges and OpportunitiesPraveen Thokala, Tushar Srivastava, Robert Smith, et al.
The European Respiratory Journal|February 6, 2016
Fractional exhaled nitric oxide for the management of asthma in adults: a systematic reviewMunira Essat, Sue Harnan, Tim Gomersall, et al.
Pharmacoeconomics|August 11, 2016
Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPaul Tappenden, Sue Harnan, Shijie Ren, et al.
Pharmacoeconomics|March 5, 2018
Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology AppraisalMatt Stevenson, Abdullah Pandor, Jean Hamilton, et al.
Pageof 7